Determination of prognostic factors in 18F-FDG PET/CT of relapsed/refractory Hodgkin lymphoma

被引：0
|
作者：
Jajroudi, M. [1 ]
Geramifar, P. [2 ]
Eslami, S. [1 ,3 ]
机构：
[1] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Med Informat, Mashhad, Iran
[2] Univ Tehran Med Sci, Res Ctr Nucl Med, Nucl Med, Tehran, Iran
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Med Informat, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-2121
引用
收藏
页码：S1908 / S1909
页数：2
相关论文
共 50 条
  • [21] Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma
    Domenico Albano
    Mattia Bertoli
    Marco Battistotti
    Carlo Rodella
    Massimo Statuto
    Raffaele Giubbini
    Francesco Bertagna
    Annals of Nuclear Medicine, 2018, 32 : 532 - 541
  • [22] Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma
    Albano, Domenico
    Bertoli, Mattia
    Battistotti, Marco
    Rodella, Carlo
    Statuto, Massimo
    Giubbini, Raffaele
    Bertagna, Francesco
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (08) : 532 - 541
  • [23] Prognostic role of baseline 18F-FDG PET/CT parameters in MALT lymphoma
    Albano, Domenico
    Bosio, Giovanni
    Camoni, Luca
    Farina, Mirko
    Re, Alessandro
    Tucci, Alessandra
    Giubbini, Raffaele
    Bertagna, Francesco
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (01) : 39 - 46
  • [24] 18F-FDG PET or PET/CT in Mantle Cell Lymphoma
    Albano, Domenico
    Treglia, Giorgio
    Gazzilli, Maria
    Cerudelli, Elisabetta
    Giubbini, Raffaele
    Bertagna, Francesco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07): : 422 - 430
  • [25] 18F-FDG PET and PET/CT in Burkitt's lymphoma
    Karantanis, Dimitrios
    Durski, Jolanta M.
    Lowe, Val J.
    Nathan, Mark A.
    Mullan, Brian P.
    Georgiou, Evangelos
    Johnston, Patrick B.
    Wiseman, Gregory A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (01) : E68 - E73
  • [26] Hodgkin's Lymphoma response to checkpoint inhibitors determined with 18F-FDG PET/CT
    Castello, Angelo
    Lopci, Egesta
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [27] Response Evaluation To Checkpoint Inhibitors by 18F-FDG PET/CT In Patients with Hodgkin Lymphoma
    Castello, A.
    Grizzi, F.
    Qehajaj, D.
    Rahal, D.
    Lutman, F.
    Lopci, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S84 - S85
  • [28] Cholesterol Granuloma Unusual Pitfall for Hodgkin Lymphoma Evaluation With 18F-FDG PET/CT
    Bahri, Haifa
    Chassagne-Clement, Catherine
    Michallet, Anne-Sophie
    Mognetti, Thomas
    Nicolas-Virelizier, Emmanuelle
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (10) : E518 - E520
  • [29] 18F-FDG PET/CT in Extranodal Burkitt Lymphoma
    Jimenez Granero, Pedro
    Garcia Gomez, Francisco Javier
    Ruiz Mercado, Marta
    Borrego Dorado, Isabel
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (09) : 748 - 749
  • [30] 18F-FDG PET/CT in primary brain lymphoma
    Albano, Domenico
    Bosio, Giovanni
    Bertoli, Mattia
    Giubbini, Raffaele
    Bertagna, Francesco
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (03) : 577 - 583
12345